Neuraxis Inc — Cash Flow (NYSE:NRXS) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -6.69 M-6.1 M-6.43 M -6.43 M Cash from investing activities -71.78 K-27.78 K-131.15 K -131.15 K Cash from financing activities 6.59 M9.74 M7.83 M 7.83 M Free cash flow -6.77 M-6.13 M-6.56 M -6.46 M

Haberler

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis

Top Stock Reports for Meta, Bank of America & Procter & Gamble

NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth

Neuraxis hisseleri karın ağrısı tedavisi için FDA onayı sonrası yükseldi

Neuraxis stock rises after FDA clearance for abdominal pain treatment

Neuraxis, PENFS cihazı için FDA onayı aldı ve piyasa teklifini genişletti

Neuraxis, 2025 üçüncü çeyrek ön finansal sonuçlarında 2,1 milyon dolar işletme zararı bildirdi

Neuraxis reports preliminary Q3 2025 financial results with $2.1 million operating loss

The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis

Top Research Reports for Alphabet, IBM & Merck

Neuraxis enters $3.3 million at-the-market equity offering agreement